Ayele Angefa, Edin Alo, Dingeta Tariku, Gudeta Robsan, Beka Jitu, Shore Hirbo
Department of Epidemiology, School of public health, Institute of health, Bule Hora University, Bule Hora, Ethiopia.
School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Sci Rep. 2024 Dec 28;14(1):30763. doi: 10.1038/s41598-024-80309-1.
Delays in development that occur during early childhood can have long-lasting consequences, potentially leading to poor academic achievement. Research has shown that the human immunodeficiency virus can have neurotropic effects, which may impact the development of the brain in infected children. However, there is a scarcity of evidence regarding developmental delays among children with human immunodeficiency virus in the study area. This study aimed to determine the prevalence of developmental delay and associated factors among children with the human immunodeficiency virus in southern Ethiopia. A cross-sectional study was undertaken among 422 children aged below five during October 30 to December 30, 2021, who acquired the human immunodeficiency virus at public hospitals. A pretested tool anthropometric measurements were utilized. To examine developmental delay, the age and stage questionnaires (version 3) were used. Descriptive statistics were performed. Bivariable and multivariable binary logistic regression models were fitted to identify potential factors associated with delays in child development. The analysis was performed using STATA version 14.2. Adjusted odds ratios with 95% confidence intervals and variables with p-values less than 0.05 were considered to be significantly associated with global developmental delay. A total of 413 under-five children with human immune virus participated, with a 97.9% response rate. Of all children, 222 (53.75%) were male, and the mean age of children was 3.5 ± 1 (± SD) years. Overall global developmental delay was 41.89% [95% CI 37-47%]. Maternal age 35 and older [AOR 2.2; 95% CI (1.11-4.3)], maternal educational status [AOR 0.47; 95% CI (0.23-0.96)], higher birth order [AOR 3; 95% CI (1.5-4)], and stunting [AOR 2.2; 95% CI (1.4-3.42)] were significant factors associated with global developmental delay. Half of the children examined demonstrated delayed development across domains. The global developmental delay constitutes a significant public health concern, underscoring the necessity for early detection initiatives including developmental screening, diagnostic evaluations, and therapeutic interventions. We found significant associations between the developmental status of the children and the maternal age, educational level of mothers, higher birth order, and stunting of under-five children. Policies should aim to enhance mother and child health services, expand access to early intervention programs, and incorporate developmental surveillance into routine pediatric care. Additional research may be necessary to elucidate the underlying causes of the high prevalence of Global developmental delay, evaluate the efficacy of current interventions, and investigate innovative approaches to mitigate developmental delays.
幼儿期出现的发育迟缓可能会产生长期影响,有可能导致学业成绩不佳。研究表明,人类免疫缺陷病毒具有嗜神经作用,这可能会影响受感染儿童的大脑发育。然而,在该研究地区,关于感染人类免疫缺陷病毒儿童发育迟缓的证据很少。本研究旨在确定埃塞俄比亚南部感染人类免疫缺陷病毒儿童发育迟缓的患病率及相关因素。2021年10月30日至12月30日期间,对422名5岁以下在公立医院感染人类免疫缺陷病毒的儿童进行了一项横断面研究。使用了经过预测试的人体测量工具。为了检查发育迟缓情况,采用了年龄和阶段问卷(第3版)。进行了描述性统计。采用双变量和多变量二元逻辑回归模型来确定与儿童发育迟缓相关的潜在因素。使用STATA 14.2版本进行分析。调整后的比值比及95%置信区间以及p值小于0.05的变量被认为与全球发育迟缓显著相关。共有413名5岁以下感染人类免疫病毒的儿童参与,应答率为97.9%。在所有儿童中,222名(53.75%)为男性,儿童的平均年龄为3.5±1(±标准差)岁。总体全球发育迟缓率为41.89%[95%置信区间37 - 47%]。母亲年龄35岁及以上[AOR 2.2;95%置信区间(1.11 - 4.3)]、母亲教育程度[AOR 0.47;95%置信区间(0.23 - 0.96)]、较高的出生顺序[AOR 3;95%置信区间(1.5 - 4)]以及发育迟缓[AOR 2.2;95%置信区间(1.4 - 3.42)]是与全球发育迟缓相关的显著因素。接受检查的儿童中有一半在各个领域都表现出发育迟缓。全球发育迟缓是一个重大的公共卫生问题,凸显了早期检测举措的必要性,包括发育筛查、诊断评估和治疗干预。我们发现儿童的发育状况与母亲年龄、母亲教育水平、较高的出生顺序以及5岁以下儿童的发育迟缓之间存在显著关联。政策应旨在加强母婴健康服务,扩大早期干预项目的可及性,并将发育监测纳入常规儿科护理。可能需要进一步研究以阐明全球发育迟缓高患病率的潜在原因,评估当前干预措施的效果,并研究减轻发育迟缓的创新方法。